Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Company profile
Ticker
SYK
Exchange
Website
CEO
Kevin Lobo
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences • Embecta ...
SEC CIK
Corporate docs
Subsidiaries
2Hip Holdings SAS • Aimago SA • Alcott Indemnity Company • Arrinex, Inc. • Berchtold + Fritz GmbH • Berchtold Consulting GmbH • Berchtold Corporation • Berchtold GmbH & Co. KG • Berchtold Holding Switzerland GmbH • BioMimetic Therapeutics USA, Inc. ...
IRS number
381239739
SYK stock data
News
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,000 Today
4 Aug 22
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022
28 Jul 22
Edward Jones Upgrades Stryker to Buy
28 Jul 22
Wells Fargo Maintains Overweight on Stryker, Lowers Price Target to $237
27 Jul 22
RBC Capital Maintains Sector Perform on Stryker, Lowers Price Target to $255
27 Jul 22
Press releases
Stryker declares a $0.695 per share quarterly dividend
3 Aug 22
Stryker reports second quarter 2022 operating results
26 Jul 22
Stryker to host conference call on July 26, 2022
30 Jun 22
Stryker Launches "Free Your Feet" Campaign to Raise Awareness About New Bunion Treatments
28 Jun 22
Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China
24 Jun 22
Analyst ratings and price targets
Current price
Average target
$237.40
Low target
$205.00
High target
$280.00
Wells Fargo
Maintains
$237.00
RBC Capital
Maintains
$255.00
Piper Sandler
Maintains
$250.00
Cowen & Co.
Maintains
$223.00
Deutsche Bank
Downgraded
$205.00
BTIG
Maintains
$244.00
Stifel
Maintains
$245.00
Morgan Stanley
Maintains
$220.00
B of A Securities
Downgraded
$215.00
Citigroup
Maintains
$280.00
Calendar
27 Jul 22
12 Aug 22
31 Dec 22
Financial summary
| Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.04B | 1.04B | 1.04B | 1.04B | 1.04B | 1.04B |
| Cash burn (monthly) | 138M | 99.75M | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 200.98M | 145.28M | n/a | n/a | n/a | n/a |
| Cash remaining | 843.02M | 898.72M | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 6.1 | 9.0 | n/a | n/a | n/a | n/a |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Aug 22 | Fletcher Robert S | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,343 | 0 | 2,343 |
| 1 Aug 22 | James Andrew Pierce | Common Stock | Payment of exercise | Dispose F | No | No | 214.75 | 380 | 81.61K | 38,791 |
| 1 Aug 22 | James Andrew Pierce | Common Stock | Option exercise | Acquire M | No | No | 0 | 765 | 0 | 39,171 |
| 1 Aug 22 | James Andrew Pierce | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 765 | 0 | 0 |
| 1 Aug 22 | Spencer S Stiles | Common Stock | Payment of exercise | Dispose F | No | No | 214.75 | 334 | 71.73K | 35,668 |
| 1 Aug 22 | Spencer S Stiles | Common Stock | Option exercise | Acquire M | No | No | 0 | 765 | 0 | 36,002 |
| 1 Aug 22 | Spencer S Stiles | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 765 | 0 | 0 |
| 3 Jun 22 | Spencer S Stiles | Common Stock | Payment of exercise | Dispose F | No | No | 234.39 | 7,970 | 1.87M | 35,237 |
| 3 Jun 22 | Spencer S Stiles | Common Stock | Option exercise | Acquire M | No | No | 64.01 | 12,505 | 800.45K | 43,207 |
| 3 Jun 22 | Spencer S Stiles | Employee Stock Option granted 02/13/2013 Common Stock | Option exercise | Dispose M | No | No | 64.01 | 12,505 | 800.45K | 0 |
Institutional ownership, Q1 2022
75.3% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1626 |
| Opened positions | 118 |
| Closed positions | 105 |
| Increased positions | 594 |
| Reduced positions | 610 |
| 13F shares | Current |
|---|---|
| Total value | 76.09B |
| Total shares | 284.74M |
| Total puts | 1.32M |
| Total calls | 1.08M |
| Total put/call ratio | 1.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 28.9M | $7.73B |
| BLK Blackrock | 23.38M | $6.25B |
| TROW T. Rowe Price | 20.16M | $5.39B |
| Greenleaf Trust | 20.06M | $5.36B |
| Wellington Management | 15.37M | $4.11B |
| STT State Street | 13.82M | $3.7B |
| Capital Research Global Investors | 10.4M | $2.78B |
| BK Bank Of New York Mellon | 7.03M | $1.88B |
| Fundsmith | 5.85M | $1.56B |
| BEN Franklin Resources | 5.45M | $1.46B |
Financial report summary
?Competition
Fuse Medical • Axogen • Smith & Nephew • Merit Medical Systems • Misonix • Orthofix Medical • Anika Therapeutics • Gentherm • Integra Lifesciences • Zimmer BiometManagement Discussion
- In 2021 we achieved reported net sales growth of 19.2%. Excluding the impact of acquisitions and divestitures, sales grew 12.6% in constant currency. We reported net earnings of $1,994 and net earnings per diluted share of $5.21. Excluding the impact of certain items, we achieved adjusted net earnings(1) of $3,474
- and adjusted net earnings per diluted share(1) of $9.09 representing growth of 22.3%.
- Effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. Refer to Note 14 to our Consolidated Financial Statements for further information.
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Good
|
|
New words:
Alongside, Asia, competitive, conduct, delay, deliver, environment, establish, FDA, indefinitely, July, macroeconomic, motion, Pacific, paid, premium, pressure, raw, reinvested, reliance, reversal, settled, shipping, spot, sterilization, subsided, suffer, unable, unanticipated, unavailability, undistributed, unique, unwilling, validation, weakening
Removed:
disciplined, duration, facilitate, ramp, recession, reduced, sensitive, slowdown, spending, working
Financial reports
Current reports
8-K
Stryker Reports Second Quarter 2022 Operating Results
26 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
9 May 22
8-K
Stryker announces board changes following Annual Meeting of Shareholders
5 May 22
8-K
Stryker Reports First Quarter 2022 Operating Results
28 Apr 22
8-K
Entry into a Material Definitive Agreement
25 Feb 22
8-K
Completion of Acquisition or Disposition of Assets
23 Feb 22
8-K
Stryker Reports 2021 Operating Results and 2022 Outlook
27 Jan 22
8-K
Regulation FD Disclosure
14 Jan 22
8-K
Entry into a Material Definitive Agreement
11 Jan 22
8-K
Other Events
3 Jan 22
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
23 Feb 22
S-3ASR
Automatic shelf registration
11 Feb 22
SC TO-T/A
Third party tender offer statement (amended)
8 Feb 22
SC TO-T/A
Third party tender offer statement (amended)
1 Feb 22
SC TO-T
Third party tender offer statement
25 Jan 22
SC TO-C
Information about tender offer
11 Jan 22
SC TO-C
Information about tender offer
7 Jan 22
SC TO-C
Information about tender offer
6 Jan 22
SC TO-C
Information about tender offer
6 Jan 22
25-NSE
Exchange delisting
30 Nov 20
Proxies
DEFA14A
Additional proxy soliciting materials
23 Mar 22
DEFA14A
Additional proxy soliciting materials
24 Mar 21
DEFA14A
Additional proxy soliciting materials
24 Mar 20
DEF 14A
Definitive proxy
24 Mar 20
DEFA14A
Additional proxy soliciting materials
18 Nov 19
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEFA14A
Additional proxy soliciting materials
4 Nov 19
Other
SD
Conflict minerals disclosure
27 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
28 Jul 21
SD
Conflict minerals disclosure
28 May 21
SD
Conflict minerals disclosure
29 May 20
CERT
Certification of approval for exchange listing
4 Dec 19
SD
Conflict minerals disclosure
31 May 19
CERT
Certification of approval for exchange listing
3 Dec 18
SD
Conflict minerals disclosure
31 May 18
SD
Conflict minerals disclosure
30 May 17
SD
Conflict minerals disclosure
30 May 16
Ownership
4
STRYKER / Robert S Fletcher ownership change
3 Aug 22
4
STRYKER / Spencer S Stiles ownership change
3 Aug 22
4
STRYKER / James Andrew Pierce ownership change
3 Aug 22
4
STRYKER / Spencer S Stiles ownership change
7 Jun 22
4
STRYKER / Allan C. Golston ownership change
6 May 22
4
STRYKER / Srikant M. Datar ownership change
6 May 22
4
STRYKER / Giovanni Caforio ownership change
6 May 22
4
STRYKER / MARY K BRAINERD ownership change
6 May 22
4
STRYKER / Rajeev Suri ownership change
6 May 22
4
STRYKER / RONDA E STRYKER ownership change
6 May 22
Patents
Utility
Twist Seal Oral Fluid Delivery Device
11 Aug 22
An oral fluid delivery device includes a housing forming at least one cavity.
Utility
Ultrasonic Surgical Handpiece Assembly
11 Aug 22
A tubing connector for integrally connecting an irrigation line, an aspiration line, and a conductor to a proximal portion of an ultrasonic surgical handpiece.
Utility
Osteotomy Plate, Plate Driver and Method for Their Use
11 Aug 22
An orthopedic plate is specifically configured for use in osteotomies, in which part of the plate extends into a portion of a first bone segment and part is external to the cortical surface of an adjacent bone segment to fix the segments to allow them to fuse.
Utility
Navigation Systems And Methods For Indicating And Reducing Line-Of-Sight Errors
11 Aug 22
A tracking device for a navigation system that includes a localizer.
Utility
Thermal System with Medication Interaction
11 Aug 22
A thermal control unit supplies temperature controlled fluid to a patient to control the patient's temperature.
Transcripts
2022 Q2
Earnings call transcript
27 Jul 22
2022 Q1
Earnings call transcript
29 Apr 22
2021 Q4
Earnings call transcript
28 Jan 22
2021 Q3
Earnings call transcript
29 Oct 21
2021 Q2
Earnings call transcript
28 Jul 21
2021 Q1
Earnings call transcript
28 Apr 21
2020 Q4
Earnings call transcript
28 Jan 21
2020 Q3
Earnings call transcript
29 Oct 20
2020 Q2
Earnings call transcript
30 Jul 20
2020 Q1
Earnings call transcript
30 Apr 20
Reddit threads
What stock in your portfolio doesn't get enough attention on this sub reddit?
9 Aug 22
Daily Discussion Thread - July 26th, 2022
26 Jul 22
Daily Discussion Thread - July 25th, 2022
25 Jul 22
Most anticipated earnings releases for the week beginning July 25, 2022
23 Jul 22
Most Anticipated Earnings Releases for the week beginning July 25th, 2022
23 Jul 22
Daily Discussion Thread - June 29th, 2022
29 Jun 22
Daily Discussion Thread - June 28th, 2022
28 Jun 22
Daily Discussion Thread - June 27th, 2022
27 Jun 22
229 S&P500 companies ($21.6t in market cap, 61.8%) report earnings in the next ~30 days
25 Jun 22
What makes a stock a meme stock?
4 Jun 22